You are here:

Celgene Ltd

Name SMC ID No Status Sub. Type
 
apremilast (Otezla) plaque psoriasis 1052/15 Accepted Full submission
apremilast (Otezla) psoriatic arthritis 1053/15 Restricted Full submission
azacitidine (Vidaza) 589/09 Not Recommended Full submission
azacitidine (Vidaza) 589/09 Accepted Resubmission
azacitidine (Vidaza) 1175/16 Not Recommended Non submission
lenalidomide (Revlimid) 441/08 Restricted Resubmission
lenalidomide (Revlimid) 441/08 Not Recommended Full submission
lenalidomide (Revlimid) 441/08 Restricted Resubmission
lenalidomide (Revlimid) 1211/16 Not Recommended Non submission
lenalidomide (Revlimid) 1096/15 Restricted Full submission
lenalidomide (Revlimid) 942/14 Accepted Full submission
paclitaxel albumin (Abraxane) 968/14 Accepted Resubmission
paclitaxel albumin (Abraxane) 1071/15 Not Recommended Non submission
paclitaxel albumin (Abraxane®) 968/14 Not Recommended Full submission
pomalidomide (Imnovid) 972/14 Not Recommended Full submission
pomalidomide (Imnovid) 972/14 Accepted Resubmission
thalidomide (Pharmion) 525/08 Superseded Full submission

Back